Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) rose 15.2% during trading on Wednesday . The company traded as high as GBX 19 ($0.24) and last traded at GBX 19 ($0.24). Approximately 432,700 shares changed hands during mid-day trading, an increase of 48% from the average daily volume of 292,733 shares. The stock had previously closed at GBX 16.50 ($0.21).
Celadon Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 196.67, a quick ratio of 6.97 and a current ratio of 1.92. The firm has a market capitalization of £9.81 million, a P/E ratio of -2.00 and a beta of -0.26. The stock’s 50 day simple moving average is GBX 18.35 and its 200 day simple moving average is GBX 25.84.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- Using the MarketBeat Dividend Tax Calculator
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Gold’s Ascent: Can Miners and ETFs Take Investors to $3,000?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
